Claims
- 1. A compound of the formula: ##STR17## or an acid addition salt thereof wherein the substituent --(CH.sub.2).sub.m --NR.sub.1 R.sub.2 is present at one of the positions indicated by a, b or c; X and Y represent hydrogen, (C.sub.1 -C.sub.6) alkyl, (C.sub.1 -C.sub.6) alkoxy, halogen, hydroxy or benzoyl,
- R.sub.1 and R.sub.2 represent hydrogen or (C.sub.1 -C.sub.6) alkyl and
- m represents the number 0.
- 2. A pharmaceutical composition for treatment of CNS disorders which comprises as active ingredient a CNS-effective amount of a compound as defined in claim 1 together with one or more pharmaceutically acceptable carriers.
- 3. A pharmaceutical composition for treatment of arrhythmic activity which comprises as active ingredient an anti-arrhythmic effective amount of a compound as defined in claim 1 together with one or more pharmaceutically acceptable carriers.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8003141 |
May 1980 |
NLX |
|
Parent Case Info
This is a continuation of application Ser. No. 268,330 filed May 29, 1981, and now abandoned.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
3732299 |
Levine et al. |
May 1973 |
|
3763233 |
Houlihan et al. |
Oct 1973 |
|
3912781 |
Finger et al. |
Oct 1975 |
|
3950425 |
Burg et al. |
Apr 1976 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
2252945 |
May 1974 |
DEX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
268330 |
May 1981 |
|